scholarly journals Three African swine fever virus genes encoding proteins with homology to putative helicases of vaccinia virus

1993 ◽  
Vol 74 (9) ◽  
pp. 1969-1974 ◽  
Author(s):  
S. A. Baylis ◽  
S. R. F. Twigg ◽  
S. Vydelingum ◽  
L. K. Dixon ◽  
G. L. Smith
2015 ◽  
Vol 89 (13) ◽  
pp. 6585-6594 ◽  
Author(s):  
Dorine Gaëlle Reteno ◽  
Samia Benamar ◽  
Jacques Bou Khalil ◽  
Julien Andreani ◽  
Nicholas Armstrong ◽  
...  

ABSTRACTGiant viruses are protist-associated viruses belonging to the proposed orderMegavirales; almost all have been isolated fromAcanthamoebaspp. Their isolation in humans suggests that they are part of the human virome. Using a high-throughput strategy to isolate new giant viruses from their original protozoan hosts, we obtained eight isolates of a new giant viral lineage fromVermamoebavermiformis, the most common free-living protist found in human environments. This new lineage was proposed to be the faustovirus lineage. The prototype member, faustovirus E12, forms icosahedral virions of ≈200 nm that are devoid of fibrils and that encapsidate a 466-kbp genome encoding 451 predicted proteins. Of these, 164 are found in the virion. Phylogenetic analysis of the core viral genes showed that faustovirus is distantly related to the mammalian pathogen African swine fever virus, but it encodes ≈3 times more mosaic gene complements. About two-thirds of these genes do not show significant similarity to genes encoding any known proteins. These findings show that expanding the panel of protists to discover new giant viruses is a fruitful strategy.IMPORTANCEBy usingVermamoeba, a protist living in humans and their environment, we isolated eight strains of a new giant virus that we named faustovirus. The genomes of these strains were sequenced, and their sequences showed that faustoviruses are related to but different from the vertebrate pathogen African swine fever virus (ASFV), which belongs to the familyAsfarviridae. Moreover, the faustovirus gene repertoire is ≈3 times larger than that of ASFV and comprises approximately two-thirds ORFans (open reading frames [ORFs] with no detectable homology to other ORFs in a database).


Virology ◽  
1991 ◽  
Vol 181 (2) ◽  
pp. 778-782 ◽  
Author(s):  
Jef M. Hammond ◽  
Linda K. Dixon

Gene ◽  
1993 ◽  
Vol 134 (2) ◽  
pp. 161-174 ◽  
Author(s):  
Rafael J. Yáñez ◽  
Javier M. Rodríguez ◽  
Mike Boursnell ◽  
JoséF. Rodriguez ◽  
Eladio Viñuela

2018 ◽  
Vol 92 (8) ◽  
Author(s):  
James K. Jancovich ◽  
Dave Chapman ◽  
Debra T. Hansen ◽  
Mark D. Robida ◽  
Andrey Loskutov ◽  
...  

ABSTRACTAfrican swine fever virus (ASFV) causes an acute hemorrhagic fever in domestic pigs, with high socioeconomic impact. No vaccine is available, limiting options for control. Although live attenuated ASFV can induce up to 100% protection against lethal challenge, little is known of the antigens which induce this protective response. To identify additional ASFV immunogenic and potentially protective antigens, we cloned 47 viral genes in individual plasmids for gene vaccination and in recombinant vaccinia viruses. These antigens were selected to include proteins with different functions and timing of expression. Pools of up to 22 antigens were delivered by DNA prime and recombinant vaccinia virus boost to groups of pigs. Responses of immune lymphocytes from pigs to individual recombinant proteins and to ASFV were measured by interferon gamma enzyme-linked immunosorbent spot (ELISpot) assays to identify a subset of the antigens that consistently induced the highest responses. All 47 antigens were then delivered to pigs by DNA prime and recombinant vaccinia virus boost, and pigs were challenged with a lethal dose of ASFV isolate Georgia 2007/1. Although pigs developed clinical and pathological signs consistent with acute ASFV, viral genome levels were significantly reduced in blood and several lymph tissues in those pigs immunized with vectors expressing ASFV antigens compared with the levels in control pigs.IMPORTANCEThe lack of a vaccine limits the options to control African swine fever. Advances have been made in the development of genetically modified live attenuated ASFV that can induce protection against challenge. However, there may be safety issues relating to the use of these in the field. There is little information about ASFV antigens that can induce a protective immune response against challenge. We carried out a large screen of 30% of ASFV antigens by delivering individual genes in different pools to pigs by DNA immunization prime and recombinant vaccinia virus boost. The responses in immunized pigs to these individual antigens were compared to identify the most immunogenic. Lethal challenge of pigs immunized with a pool of antigens resulted in reduced levels of virus in blood and lymph tissues compared to those in pigs immunized with control vectors. Novel immunogenic ASFV proteins have been identified for further testing as vaccine candidates.


2020 ◽  
Vol 23 (04) ◽  
pp. 21-26
Author(s):  
A.K. Sibgatullova ◽  
◽  
M.E. Vlasov ◽  
I.A. Titov ◽  
◽  
...  

Sign in / Sign up

Export Citation Format

Share Document